Business Standard

Zydus Cadila testing a multi-variant Covid-19 vaccine on animals

Mixing multiple strains to get what is called a multi-variant vaccine may be a way to get better immunity, scientists feel

Coronavirus vaccine
Premium

Sohini Das Mumbai
Ahmedabad-based Cadila Healthcare (Zydus Cadila), which has developed the first approved DNA vaccine in the world for Covid-19, is testing a multi-variant Covid-19 vaccine on animals, a senior company official said.

“We have completed our development for almost eight strains of the Sars-Cov-2 virus. We are now doing animal studies to see which of these constructs work the best to neutralise more mutations of Sars-CoV-2. It can be a vaccine construct using one strain or may be two strains,” said Sharvil Patel, MD, Zydus Cadila.

Patel said the vaccine was in the product development stage and animal studies would show

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 31 2021 | 11:08 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com